Malaria vaccine development is a multinational effort involving governments, universities, nonprofits, philanthropists, and pharmaceutical companies to create effective vaccines, such as the R21/Matrix-M vaccine, which in late 2021 became the first malaria vaccine recommended by the World Health Organization for widespread use.